Kevin Comcowich - 06 Jun 2023 Form 4 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Role
Director
Signature
Kevin Comcowich, by Attorney-in-fact, Solaeta Chan
Issuer symbol
RKDA
Transactions as of
06 Jun 2023
Net transactions value
$0
Form type
4
Filing time
16 Jun 2023, 12:40:28 UTC
Previous filing
03 Jun 2022
Next filing
21 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RKDA Stock Option (Right to Buy) Award $0 +2,186 +64% $0.000000 5,587 06 Jun 2023 Common Stock 2,186 $4.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option will become 100% vested and exercisable on the earlier to occur of (i) June 6, 2024 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service.